Evidence map›Paper›PMID 40799794›Full record

ArticleOpen forum infectious diseases2025

Descriptive Epidemiology of the 2022-2023 Cholera Outbreak in Lebanon and Lessons Learned in the Context of a Humanitarian Emergency Situation.

Firass Abiad, Abdinasir Abubakar, Nadeen Hilal, Wahida Ghalayini, Nada Ghosn, Rita Feghali, Abbas Jouni, Maryo Baakliny, Moubadda Assi, Solara Sinno and 2 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Firass AbiadMinistry of Public Health, Beirut, Lebanon.ORCID https://orcid.org/0000-0002-8822-7431
Abdinasir AbubakarWorld Health Organization, Beirut, Lebanon.ORCID https://orcid.org/0000-0002-5131-5518
Nadeen HilalMinistry of Public Health, Beirut, Lebanon.
Wahida GhalayiniMinistry of Public Health, Beirut, Lebanon.
Nada GhosnMinistry of Public Health, Beirut, Lebanon.ORCID https://orcid.org/0000-0003-3549-703X
Rita FeghaliMinistry of Public Health, Beirut, Lebanon.
Abbas JouniMinistry of Public Health, Beirut, Lebanon.
Maryo BaaklinyMinistry of Public Health, Beirut, Lebanon.ORCID https://orcid.org/0000-0002-2943-5441
Moubadda AssiWorld Health Organization, Beirut, Lebanon.
Solara SinnoWorld Health Organization, Beirut, Lebanon.
Alissar RadyWorld Health Organization, Beirut, Lebanon.
Abrar Ahmad ChughtaiSchool of Population Health, University of New South Wales, Sydney, Australia.ORCID https://orcid.org/0000-0003-4203-7891

Funding

World Health Organization 001
6 · The paper itself

Abstract

On 6 October 2022, the first cholera outbreak in 3 decades was reported in Lebanon by the Ministry of Public Health. The outbreak spread across all 8 governorates (23 of 26 districts). From October 2022 to June 2023, 8072 cases (including 671 laboratory-confirmed cases) and 23 deaths were reported, resulting in a case fatality ratio of 0.28%. The outbreak was successfully contained through the implementation of coordinated multisectoral prevention and control strategies, supported by national and international stakeholders. The cholera vaccine campaign with a 1-dose strategy was started in November 2022. The proportion of vaccinated people among the target population evolved from 4.8% in November 2022 to 30.6% in December 2022, 34.2% in January 2023, and 45.3% in February 2023. This article describes the epidemiology of the cholera outbreak in Lebanon and summarizes the outbreak response in the context of a humanitarian emergency.

Indexed as

choleracholera vaccineLebanonoutbreak

Identifiers

PMID40799794
PMCPMC12343115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.